Equifax's Cloud Not A Moat, Analyst Says In Downgrade Slashing Estimates

Bank of America Securities downgraded Equifax (EFX) from Buy to Neutral, reducing its price target to $285 from $300 and cutting 2025 and 2026 EPS estimates. The downgrade reflects BofA's disappointment with Equifax's unrevised long-term growth outlook, citing delays in cloud platform migration and a slowdown in the mortgage market. Analysts are concerned the cloud transformation may not provide a sufficient competitive moat, with future growth heavily reliant on product innovation and an uncertain mortgage market recovery. Following the news, EFX stock traded lower.

Analysis

Bank of America has downgraded Equifax (EFX) to Neutral from Buy and reduced its price target to $285 from $300, reflecting disappointment with the company's unchanged long-term growth outlook from its 2021 investor day. The analyst, Joshua Dennerlein, noted that Equifax underperformed its historical targets due to delays in its cloud platform migration and a slowdown in the mortgage market. Consequently, BofA has lowered its 2025 adjusted EPS estimate for EFX to $7.58 and its 2026 estimate to $8.91. The core of the downgrade rests on the view that the company's cloud transformation does not constitute a durable competitive moat, making future growth heavily dependent on product innovation and a recovery in the mortgage market, the timing of which is highly uncertain. While Equifax's own Q2 and FY2025 guidance is largely in line with consensus, BofA's revised outlook suggests a more tempered growth trajectory, a sentiment reflected in the stock's 1.65% decline to $251.47 following the news.

Key Decisions for Investors

• Investors should re-evaluate the long-term growth thesis for Equifax, as a key analyst now views its cloud strategy as insufficient for a competitive moat, placing greater weight on uncertain catalysts.
• Monitor leading indicators for the U.S. mortgage market closely, as its recovery is now framed as the most significant driver for Equifax's performance, but the timing remains a major risk factor.
• Consider that with a new Neutral rating and a lower price target of $285, the risk/reward profile has shifted, warranting a review of positions relative to the newly articulated concerns about future growth.
• Pay close attention to future earnings calls for evidence of accelerated product innovation, as this is highlighted as the primary company-controlled lever to achieve its long-term growth targets.